If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
173.50    0.00 (0.00%)
Bid:
173.00
Ask:
177.50
Spread: 4.50 (2.601%)
Market Cap: £33.88m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Board change

2 Aug 2022 07:00

RNS Number : 5264U
Palace Capital PLC
02 August 2022
Β 

2 August 2022

Palace Capital plc

("Palace Capital" or the "Company")

Board change

Palace Capital (LSE:PCA), the Main Market property investment company that owns a diversified portfolio of UK commercial real estate in carefully selected locations outside of London, announces the following change to its Board and committee responsibilities.

Mark Davies, ACA has been appointed as an independent Non-Executive Director and joined the Board with immediate effect. A highly experienced FTSE250 executive, Mark has extensive experience of Chairman, CEO and CFO roles in listed companies and private equity. He was a Co-founder Director of New River REIT plc ("New River") and helped take the Company from IPO to the FTSE250 in seven years. He was CFO of New River for over twelve years and, working alongside his role as CFO, was also CEO/Chairman of Hawthorn Leisure Limited ("Hawthorn") for five years. Mark stood down from the Board of New River following the announcement of the sale of Hawthorn in July 2021 but remained as CEO of Hawthorn until its successful sale to Admiral Taverns in August 2021.

In addition to his role as a Non-Executive Director, Mark will chair both the Audit Committee and Remuneration Committee and will also be the Senior Independent Director.

Steven Owen will chair the Nominations Committee and Matthew Simpson, CFO, will chair the ESG Committee.

Steven Owen, Interim Executive Chairman, commented:

"Mark's track record, experience and knowledge of property and capital markets will be invaluable in enabling the Board to execute the Company's strategy of maximising cash returns to shareholders. The Board is looking forward to working with Mark in delivering this goal."

Mark Davies, Non-Executive Director, commented:

"I'm delighted to have joined the Board of Palace Capital as a Non-Executive Director. I've followed the Company since its inception and I'm looking forward to working alongside Steven and the Management Team to deliver Shareholder Value."

Β 

There are no other matters that require disclosure under 9.6.13R of the UK Listing Rules.

Β 

For further information:

Β 

Palace Capital plc

Steven Owen, Interim Executive ChairmanTel. +44 (0)20 3301 8330

Β 

FTI Consulting

Dido Laurimore/ Andrew Davis

Tel: +44 (0)20 3727 1000

palacecapital@fticonsulting.com

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAPBMRTMTTMBPT
Date   Source Headline
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 202411:03 amRNSResult of AGM
24th Jul 202410:53 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDISPOSALS AND CASH UPDATE
22nd Jul 20248:55 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
17th Jul 20242:30 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSResult of Tender Offer
9th Jul 202410:45 amRNSResult of General Meeting
19th Jun 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
13th Jun 20247:00 amRNSTender Offer
6th Jun 20247:00 amRNSPreliminary Results for year ended 31 March 2024
4th Jun 20247:00 amRNSNotice of Results
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.